Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04303403 | Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma | unknown | Phase 1 | 48 | National Cancer Centre, SingaporeOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT06060704 | Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC. | unknown | Phase 2 | 33 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 11, 2023 |
| clinicaltrials |
| NCT06065592 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms(CAT_PB) | unknown | Phase 1 | 500 | Lebanese UniversityOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06071598 | The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation | unknown | — | 15 | IRCCS San RaffaeleOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT04257526 | Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program(LIFE-SCREEN) | unknown | N/A | 500 | International Agency for Research on CancerOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer(IDEA) | unknown | Phase 3 | 2,000 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT06056726 | Evaluation of Surgical Complications and DFS in Obese Rectal Cancer Patients | unknown | — | 90 | Federico II UniversityOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT02614534 | Clinical Trial to Evaluate Safety and Efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) With Mitomycin C Used During Surgery for Treatment of Locally Advanced Colorectal Carcinoma(HIPECT4) | unknown | Phase 3 | 200 | Maimónides Biomedical Research Institute of CórdobaOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT04033107 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | unknown | Phase 2 | 30 | Zhongnan HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | unknown | Phase 2 | 140 | IFOM ETS - The AIRC Institute of Molecular OncologyOTHER | 2 | Sep 28, 2023 | clinicaltrials |
| NCT05734820 | Computer-aided Detection During Screening Colonoscopy | unknown | N/A | 312 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05176964 | Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer | unknown | — | 50 | Fujian Medical University Union HospitalOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05643105 | Anastomotic Leakage After Colon Cancer Surgery(ANACO II) | unknown | — | 1,628 | Hospital San Carlos, MadridOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06049901 | Nitazoxanide in Patients With Metastatic Colorectal Cancer | unknown | Phase 3 | 60 | Tanta UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06050447 | Factors Affecting the Results of Treatment of Patients With Colorectal Cancer | unknown | — | 1,200 | Immanuel Kant Baltic Federal UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT05209750 | FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma(FAPI-CRC1) | unknown | N/A | 30 | The Netherlands Cancer InstituteOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06048458 | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping(PC-TOX) | unknown | — | 75 | University College, LondonOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06026618 | Perioperative Management of Preoperative Anemia in Colorectal Cancer | unknown | — | 1,294 | Consorci Sanitari IntegralOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT05304741 | The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening | unknown | — | 30 | Chongqing University Cancer HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06011473 | Continuous Glucose Monitoring for Colorectal Cancer(CGM-CRC) | unknown | N/A | 40 | Medical University of GdanskOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06019312 | L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients | unknown | N/A | 60 | Medical University of GdanskOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05555901 | The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer | unknown | Phase 2 | 116 | Fudan UniversityOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06017141 | Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study | unknown | Phase 2 | 80 | University of Kansas Medical CenterOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06018077 | Chemerin in Colorectal Cancer and Its Relationship With Diet Quality | unknown | — | 104 | Hacettepe UniversityOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT02031939 | Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer | unknown | Phase 3 | 556 | Sun Yat-sen UniversityOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT06010888 | Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC | unknown | Phase 2 | 92 | Fudan UniversityOTHER | 1 | Aug 25, 2023 | clinicaltrials |
| NCT05957016 | Neoadjuvant CIETAI With Concurrent Chemoradiotherapy in Local Advanced Rectal Cancer | unknown | Phase 2 | 90 | Third Military Medical UniversityOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT06003998 | Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab(INTERACT-II) | unknown | Phase 2 | 85 | Catharina Ziekenhuis EindhovenOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT04984369 | The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment | unknown | Phase 2 | 50 | Shanghai Henlius BiotechINDUSTRY | 1 | Aug 21, 2023 | clinicaltrials |
| NCT05999227 | 68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy | unknown | N/A | 20 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 21, 2023 | clinicaltrials |
| NCT04659382 | Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer(SIRTCI) | unknown | Phase 2 | 52 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT04798612 | Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression(IPOS) | unknown | Phase 2 | 68 | Zealand University HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05127759 | The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation | unknown | Phase 2 | 25 | Shanghai Henlius BiotechINDUSTRY | 1 | Aug 8, 2023 | clinicaltrials |
| NCT03619668 | Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective Treatment(AMPERE) | unknown | — | 16 | Aalborg University HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04048421 | Feasibility and Safety of Hybrid Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Colon Cancer | unknown | N/A | 55 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05973266 | The Effect of Mobile Application-Based Bowel Preparation Training on the Patient's Education Whom Colonoscopy is Planned | unknown | N/A | 160 | Kubra SengorOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04262635 | Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer(C-CLASSIC) | unknown | Phase 3 | 80 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
| NCT03950154 | Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer | unknown | Phase 3 | 198 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05842525 | Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer | unknown | Phase 2 | 42 | Hunan Cancer HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05911789 | Online Adaptive Radiation Therapy for Rectal Cancer | unknown | Phase 1 / Phase 2 | 15 | Peking Union Medical College HospitalOTHER | 0 | Aug 1, 2023 | clinicaltrials |
| NCT05961423 | Robotic vs Laparoscopic D3-D4 Lymphadenectomy for Colorectal Cancer | unknown | N/A | 286 | National Taiwan University HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05969938 | Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology | unknown | — | 50 | WeiWei XiaoOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05970302 | XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC | unknown | Phase 2 | 52 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05970705 | Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC | unknown | Phase 2 | 101 | Fudan UniversityOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05648955 | Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment(ALLIES) | unknown | Early Phase 1 | 118 | Nutricia ResearchINDUSTRY | 1 | Jul 28, 2023 | clinicaltrials |
| NCT05891301 | Construction and Validation of Risk Prediction Model for Gastrointestinal Dysfunction of Patient With Colorectal Cancer | unknown | — | 737 | Sun Yat-sen UniversityOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05963087 | Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer | unknown | N/A | 22 | Zhejiang Cancer HospitalOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05916443 | Dissecting the Biology of Early-onset Colorectal Cancer | unknown | — | 30 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Jul 24, 2023 | clinicaltrials |
| NCT05957744 | Nutritional Risk Factors and Colorectal Surgery | unknown | — | 120 | University Clinic Dr Dragisa Misovic-DedinjeOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05726188 | Predictors of Disease Recurrence After Curative Surgery for Stage I Colon Cancer(CORE1) | unknown | — | 2,000 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 2 | Jul 21, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2023source: clinicaltrials